Disclaimer

The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Day

July 31, 2025
PRESS RELEASE NON-REGULATED INFORMATION 31 July 2025, 6:00 pm CET Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis.  Without treatment, there is a significant risk of complications that are life threatening and require emergency surgery Effective management of ascites is necessary for elective surgical repair in such patients The...
Read More